Hallett David 4

What Happened

• David Hallett, Chief Scientific Officer of Recursion Pharmaceuticals (RXRX), had 26,657 shares disposed/withheld on May 15, 2026 to satisfy tax withholding related to the net settlement of restricted stock units. The withheld shares were recorded at $3.04 per share for a total value of $81,037.

Key Details

• Transaction date: 2026-05-15; Filing date: 2026-05-19 (filed timely).
• Transaction type/code: F — shares withheld to cover tax withholding (disposition on Form 4).
• Amount: 26,657 shares withheld at $3.04 per share; total value ≈ $81,037.
• Footnote: F1 — issuer withheld shares to satisfy its tax withholding/remittance obligations in connection with net settlement of RSUs.
• Shares owned after transaction: Not specified in the provided filing details.

Context

• This was an administrative tax-withholding (net settlement of RSUs), not an open-market sale. Withheld shares are retained by the issuer to cover taxes and do not necessarily reflect the insider’s view of the company’s stock.